Biosensors & POCT– category –
-
Nix Biosensors Launches AI-Powered Intelligence Layer for Nix Pro, Revolutionizing Hydration Data Utilization in Elite Organizations
Fitt Insider USA Overview Nix Biosensors announced the integration of an AI-powered intelligence layer within its Nix Pro hydration monitoring device. This new feature aims to fundamentally transform how elite organizations utilize hydra... -
DexCom Reports Strong Q2 2026 Results with 13% Revenue Growth, 50% Operating Income Surge
Stock Titan USA Overview DexCom announced robust Q2 2026 financial results, with revenue up 13% year-over-year, driven by increased disposable sensor volumes and an expanding customer base. The company also reported a significant 50% ris... -
Dexcom G7 Achieves Industry-Leading Accuracy with MARD 8.2-8.5% in Adults, Clinical Data Confirms
diabetesknow.com USA Overview Newly compiled clinical data for 2026 ranks the Dexcom G7 as the most accurate continuous glucose monitor (CGM), reporting a mean absolute relative difference (MARD) of approximately 8.2–8.5% in adults. This... -
bioRxiv Preprint: SMART-NeuroDx Unveils Reagent-Free, Machine-Learning Biosensor Platform for Point-of-Care Dementia Screening
bioRxiv International Overview A preprint on bioRxiv introduces SMART-NeuroDx, a reagent-free, multianalyte biosensor platform featuring a machine-learning readout for point-of-care dementia screening. The platform utilizes a four-channe... -
Intelligent Bio Solutions Clears Cybersecurity and Software Review Items Ahead of FDA 510(k) Submission, Advancing US Market Entry
Intelligent Bio Solutions (INBS) News and Media USA Overview Intelligent Bio Solutions Inc. announced it has addressed all cybersecurity and software-related review items for its upcoming FDA 510(k) submission. This milestone, achieved a... -
MedWatch Technologies Secures $15 Million in Series A Funding for Non-Invasive Glucose Biosensor and Lifestyle Coaching Platform
Cure USA Overview MedWatch Technologies has secured $15 million in Series A financing to accelerate the development of its non-invasive biosensor for glucose-related insights and an integrated lifestyle coaching platform. This capital in... -
Microfluidic Platform Enables Multiplexed Detection of Breast Cancer-Specific miRNA and Protein Biomarkers on Exosomes, ACS Analytical Chemistry Reports
Analytical Chemistry - ACS Publications USA Overview Research published in ACS Analytical Chemistry describes the development of a microfluidic chip for multiplexed detection of breast cancer-specific miRNA and protein biomarkers on exos... -
Biolinq’s Needle-Free Autonomous Wearable Biosensor, Shine™, Receives FDA De Novo Classification, Establishing New Device Category
EvoNexus USA Overview Biolinq, an EvoNexus graduate company, announced that its Shine™ device, a needle-free autonomous wearable biosensor, has received FDA De Novo classification. This classification creates a new regulatory category fo... -
Eindhoven University of Technology’s GlucoPilot Project Develops AI-Powered Personal Glucose Coach with Smart Ring and Lifestyle Data Integration
Eindhoven University of Technology Netherlands Overview The 'GlucoPilot' project, involving researchers from Eindhoven University of Technology, is developing an AI-powered personal glucose coach. This system integrates continuous glucos... -
Labman Develops Next-Gen POCT HPV Screening Device under EU ELEVATE Project: Rapid Detection of 14 HPV Strains and Two Biomarkers
News-Medical.net UK Overview Labman has developed a next-generation point-of-care (POCT) HPV screening device as part of the EU-funded ELEVATE project. This compact, portable instrument utilizes microfluidic 'lab-on-a-chip' technology to...
